Pancreatic Cancer Trial, Recruiting NCT07249775 Sponsor: H. Lee Moffitt Cancer Center and Research Institute Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07249775
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You have been diagnosed with a type of pancreatic cancer (such as pancreatic ductal adenocarcinoma or similar), either confirmed by a tissue or cell sample, or strongly suspected and expected to be confirmed early in the study period
  • Your cancer may be at any stage — including early, locally advanced, or spread to other parts of the body
  • You may or may not have already had surgery for your cancer
  • Your treatment plan is expected to include medication-based treatment (such as chemotherapy) for your pancreatic cancer
  • You are well enough to carry out some daily activities, though not necessarily all (confirm with trial site what level of fitness is required)
  • You are able to eat and drink by mouth and are not currently being fed through a tube or a drip into a vein
  • You are able to read and speak English
  • You are able to give written consent to take part in the study

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You are currently being fed through a feeding tube or receiving nutrition through a drip directly into a vein
  • You have a build-up of fluid in your abdomen or other signs that your illness is in a serious, unstable state
  • You have a history of a blockage in your bowel, or any gut condition that makes it difficult for you to eat normally
  • You have a severe or poorly controlled mental health condition (such as psychosis or dementia) that could make it hard to take part in the study
  • You have another serious, uncontrolled health condition (such as a significant infection, heart failure, or liver failure) that could affect your ability to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ghulam Rasool, PhD, Moffitt Cancer Center

Phone: 813-745-0279

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 October 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

AI Model Performance; Survey Completion Rate; Wearable Adherence; Quality of Life Change; Physical Activity Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov